<DOC>
	<DOCNO>NCT01736371</DOCNO>
	<brief_summary>The aim study quantify difference cisatracurium sufentanil consumption , recovery period , patient balance general anesthesia 1 % sevoflurane patient sevoflurane general anesthesia , use close loop computer control infusion . Investigators investigate effect recovery period sufentanyl consumption .</brief_summary>
	<brief_title>Analysis Cisatracurium Consumption Balanced Anesthesia With 1 % Sevoflurane , With Only Sevoflurane , Using Closed-loop Computer Controlled System Infusion .</brief_title>
	<detailed_description>156 patient American Society Anesthesiologists ( ASA ) physical status I II assign three group . The patient schedule elective general surgery general anesthesia duration two four hour . All patient induce Etomidate ( 0.2mg/kg ) , Midazolam ( 0.05-0.1mg/kg ) , Sufentanil ( 0.3-0.5µg/kg ) bolus dose Cisatracurium ( 0.15mg/kg ) . Patients age 20 65 . The maintenance anesthesia group vary follow : Patients Group 1 maintain Total Intravenous Anesthesia , Group 2 Sevoflurane 1 % propofol infusion , Group 3 sevoflurane . Muscle paralysis maintain use closed-loop computer gate infusion Cisatracurium keep T1 &lt; 1 % give increase infusion rate intra-operatively require . Analgesia maintain intermittent bolus dose 10-20 µg Sufentanil .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<criteria>Patients age 20 65 . Patients ASA 1 2 . Patients elective abdominal general surgery Patients follow disease exclude , since know cause generalize neuromuscular weakness : Neuromuscular junction disorder ( e.g.. myasthenia gravis ) Myopathies ( e.g.. Muscular Dystrophies , Rhabdomyolysis ) Peripheral Neuropathies ( e.g . GuillainBarre Syndrome , Polyneuropathies ) Encephalopathies ( Septic Toxicmetabolic Encephalopathy ) Patients renal liver disease . Patients send intubated ICU surgery . Patients refusal</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Sevoflurane</keyword>
	<keyword>Cisatracurium infusion consumption</keyword>
	<keyword>Closed loop computer control system</keyword>
	<keyword>Recovery Index</keyword>
</DOC>